Analysts Set Simulations Plus, Inc. (NASDAQ:SLP) PT at $51.40

Simulations Plus, Inc. (NASDAQ:SLP) has been assigned a consensus rating of “Buy” from the seven brokerages that are currently covering the company, MarketBeat reports. One analyst has rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating on the company. The average 1-year price objective among brokerages that have issued a report on the stock in the last year is $51.40.

Several equities research analysts have issued reports on SLP shares. StockNews.com downgraded Simulations Plus from a “hold” rating to a “sell” rating in a research report on Monday, November 4th. KeyCorp began coverage on Simulations Plus in a research note on Monday, July 29th. They issued an “overweight” rating and a $47.00 target price for the company. Stephens began coverage on Simulations Plus in a report on Friday, November 15th. They set an “overweight” rating and a $39.00 target price for the company. William Blair reissued an “outperform” rating on shares of Simulations Plus in a report on Wednesday, November 6th. Finally, BTIG Research reduced their price objective on shares of Simulations Plus from $60.00 to $50.00 and set a “buy” rating for the company in a research note on Thursday, October 24th.

Insider Activity

In other news, Director Walter S. Woltosz sold 20,000 shares of the firm’s stock in a transaction on Tuesday, October 1st. The shares were sold at an average price of $31.26, for a total transaction of $625,200.00. Following the sale, the director now owns 3,481,592 shares in the company, valued at approximately $108,834,565.92. This trade represents a 0.57 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. In the last 90 days, insiders sold 60,750 shares of company stock worth $1,905,655. 20.90% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Simulations Plus

A number of large investors have recently added to or reduced their stakes in SLP. Tributary Capital Management LLC lifted its holdings in shares of Simulations Plus by 54.7% in the 3rd quarter. Tributary Capital Management LLC now owns 325,567 shares of the technology company’s stock worth $10,425,000 after acquiring an additional 115,122 shares during the last quarter. Silvercrest Asset Management Group LLC bought a new stake in Simulations Plus in the first quarter worth $4,717,000. Royce & Associates LP boosted its position in Simulations Plus by 28.8% during the third quarter. Royce & Associates LP now owns 237,416 shares of the technology company’s stock valued at $7,602,000 after buying an additional 53,092 shares during the period. Dimensional Fund Advisors LP grew its stake in shares of Simulations Plus by 10.1% during the second quarter. Dimensional Fund Advisors LP now owns 414,005 shares of the technology company’s stock valued at $20,128,000 after buying an additional 37,992 shares during the last quarter. Finally, Congress Asset Management Co. increased its holdings in shares of Simulations Plus by 22.5% in the third quarter. Congress Asset Management Co. now owns 206,542 shares of the technology company’s stock worth $6,613,000 after buying an additional 37,914 shares during the period. Hedge funds and other institutional investors own 78.08% of the company’s stock.

Simulations Plus Stock Performance

SLP stock opened at $31.32 on Monday. The stock has a fifty day moving average of $30.80 and a 200-day moving average of $38.24. Simulations Plus has a fifty-two week low of $27.07 and a fifty-two week high of $51.22. The company has a market capitalization of $628.59 million, a price-to-earnings ratio of 63.92 and a beta of 0.71.

Simulations Plus (NASDAQ:SLP) last issued its earnings results on Wednesday, October 23rd. The technology company reported $0.06 earnings per share for the quarter, topping analysts’ consensus estimates of $0.04 by $0.02. Simulations Plus had a net margin of 14.15% and a return on equity of 6.16%. The firm had revenue of $18.70 million during the quarter, compared to analyst estimates of $19.73 million. During the same quarter last year, the business earned $0.18 earnings per share. The company’s quarterly revenue was up 19.9% on a year-over-year basis. Equities analysts predict that Simulations Plus will post 1.12 EPS for the current year.

About Simulations Plus

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.